Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
REGULATED INFORMATION ABLYNX ANNOUNCES HALF-YEAR RESULTS FOR 2015 Caplacizumab on track to enter Phase III in acquired TTP, with Ablynx committed to lead commercialisation in Europe and the USA 4 Phase II clinic
Add to Reading List
Document Date: 2015-08-26 11:07:31
Open Document
File Size: 524,09 KB
Share Result on Facebook
REGULATED INFORMATION ABLYNX ANNOUNCES HALF-YEAR RESULTS FOR 2015 Caplacizumab on track to enter Phase III in acquired TTP, with Ablynx committed to lead commercialisation in Europe and the USA 4 Phase II clinic